SCHEMBL5605890

SCHEMBL5605890

C1=CON(c2ccccn2)N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLD1 Q13393 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPK1 P28482 2/20 0.37
GAA P10253 1/20 0.37
POLB P06746 2/20 0.36
CYP1A2 P05177 2/20 0.36
EP300 Q09472 1/20 0.36
KAT2B Q92831 1/20 0.36
HPGD P15428 2/20 0.36
CRBN Q96SW2 1/20 0.36
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11522594 0.67
SCHEMBL6056002 0.66 PLD1 (0.40) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL6237477 0.66 PLD1 (0.47) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL5314104 0.63 PLD1 (0.49) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL28379997 0.63 SMN1; SMN2 (0.55) PLD1SMN1; SMN2ALDH1A1HTTMAPK1
SCHEMBL3996357 0.63 ALOX5 (0.46) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL9283452 0.63 PLD1 (0.44) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL694941 0.63 CRBN (0.42) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL5934829 0.62 RAB9A (0.41) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT
SCHEMBL1461902 0.62 SMN1; SMN2 (0.48) PLD1SMN1; SMN2ALDH1A1HSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761485-A1 AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS Schering AG (DE) 2007-03-14 EP disclosed
EP-1664003-A1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2006-06-07 EP disclosed
WO-2005028454-A1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed
WO-2004108661-A1 AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS (US) 2004-12-16 WO disclosed
EP-1383748-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-01-28 EP disclosed
WO-2002051983-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-07-04 WO disclosed